Synonyms: compound 10 [WO2023283425A1] | PLX4545
Compound class:
Synthetic organic
Comment: PLX-4545 is an orally bioavailable molecular glue degrader of the T cell transcription factor IKZF2 (Helios; IKZF2; Q9UKS7). It promotes selective cereblon-mediated degradation of IKZF2 with the intention of enhancing T cell-mediated anti-tumour immune responses. The chemical structure of PLX-4545 was revealed during the First-Time Disclosures session at the ACS Fall 2024 meeting (Denver, Colorado). This matches compound 10 as claimed in Plexium's patent WO2023283425A1 [1].
|
|
Bioactivity Comments |
DC50 for IKZF2 degradation is 6 nM, with maximum degradation of ~80% (at 1 μM) [1]. Does not significantly degrade IKZF1 or IKZF3. |